Ads
related to: regeneron
Search results
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 9 hours agoOver the past year, many Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders sold a significant...
JD Supra: Updates on Aflibercept BPCIA Litigation
JD Supra· 3 hours agoAs we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed a motion seeking to establish a multi-district litigation ...
Why Regeneron (REGN) Could Beat Earnings Estimates Again
Zacks via Yahoo Finance· 3 days agoRegeneron (REGN) has an impressive earnings surprise history and currently possesses the right...
Regeneron commits $500M to new venture capital fund
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: Regeneron Pharmaceuticals is getting into biotechnology investing, committing $500 million over the next five years to an independent venture...
Regeneron Pharmaceuticals’ (REGN) Neutral Rating Reiterated at Cantor Fitzgerald
ETF DAILY NEWS· 2 days agoCantor Fitzgerald reaffirmed their neutral rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) in a research note released on Monday morning, Benzinga ...
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond
FierceBiotech· 4 days agoRegeneron is joining its pharma peers in the venture investing sector, committing up to $500 million...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals,...
Morningstar· 1 day agoNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron ...
Bank of America Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $720.00
ETF DAILY NEWS· 5 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price lifted by Bank of America from $710.00 to $720.00 in a research note published on Friday morning ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Reduced by Sandy Spring Bank
ETF DAILY NEWS· 6 days agoSandy Spring Bank cut its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 73.3% during the fourth quarter, HoldingsChannel.com reports. The ...
Vontobel Holding Ltd. Has $6.24 Million Stock Holdings in Regeneron Pharmaceuticals, Inc....
ETF DAILY NEWS· 3 days agoVontobel Holding Ltd. trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 35.2% in the fourth quarter, HoldingsChannel reports ...
